The emerging treatment of tirzepatide peptide represents a major breakthrough in the management of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide affects dual pathways – GLP-1 and GIP – https://tirzepatidepeptide848947.bloggosite.com/50060565/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment